July 31, 2016 4:01 AM ET


Company Overview of Mercator MedSystems, Inc.

Company Overview

Mercator MedSystems, Inc., a medical technology company, develops catheter-guided microfluid injection systems for site-specific delivery of therapeutic agents directly across various blood vessels. The company offers Cricket and Bullfrog micro-infusion catheters, which are designed to inject therapeutic agents directly and non-systemically through blood vessel walls into deep tissues. It offers products for the treatment of blood vessel restenosis caused by inflammation after vascular injury; micro-infusion devices to infuse drugs, genes, and cells without material loss in viability or potency; inflammation and restenosis treatment for peripheral artery disease; and micro-infusion catheter ...

2200 Powell Street

Suite 530

Emeryville, CA 94608

United States

Founded in 1999





Key Executives for Mercator MedSystems, Inc.

Chief Executive Officer and Director
Age: 51
Co-Founder, President and Chief Science & Technology Officer
Co-Founder and Director
Compensation as of Fiscal Year 2016.

Mercator MedSystems, Inc. Key Developments

Mercator MedSystems, Inc. Announces First Patient Enrolled in Below the Knee Clinical Trial

Mercator MedSystems, Inc. announced their first patient enrollment from Bad Krozingen, Germany, in the company's LIMBO-PTA clinical trial. This trial combines localized drug delivery using the company's proprietary Bullfrog Micro-Infusion Device of an off-the-shelf anti-inflammatory steroid (dexamethasone) with angioplasty. The study measures the benefit of adding drug delivery to the catheter-based re-opening of arteries below the knee in patients suffering from critical limb ischemia (CLI). In vessels below the knee, while balloon angioplasty is able to open the clogged artery, a scarring process usually leads to re-obstruction of the vessel within 6 months of the procedure. The purpose of locally delivering an inexpensive generic anti-inflammatory drug to the vessel is to extinguish the biological signals that cause the buildup of scar tissue and lead to restenosis. Two CLI trials are planned by Mercator, both of which are randomized, controlled trials: the German study (LIMBO-PTA), which pairs the therapy with angioplasty, and a United States study (LIMBO-ATX) which combines the therapy with atherectomy and has been submitted to the FDA. In angioplasty procedures, a high-pressure balloon is used to compress plaque and force the artery open, while atherectomy utilizes catheters with cutting blades or rough spinning surfaces to physically remove plaque from the artery. Both of these procedures are well known to cause blood vessel inflammation that leads to the re-occlusive scarring process.

Mercator MedSystems, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 02:40 PM

Mercator MedSystems, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 02:40 PM. Venue: Westin Grand Central, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mercator MedSystems, Inc., please visit www.mercatormed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.